Advanced Respiratory PCR Panel

Comprehensive, Rapid, and Clinically Actionable Detection

Redefining Respiratory Diagnostics

Respiratory infections are among the most common causes of acute illness, hospitalization, and antimicrobial misuse. Clinical symptoms often overlap across viral and bacterial etiologies—making accurate diagnosis challenging.

Traditional testing methods can be:

Our multiplex Respiratory PCR Panel provides broad, rapid detection of viral and bacterial pathogens, enabling timely, targeted clinical decisions.

Respiratory Pathogen Panel

Bacteria
14 targets
Bordetella parapertussis
Bac (gram-negative)
Bordetella spp. (pertussis/holmesii)
Bac (gram-negative)
Chlamydophila pneumoniae
Bac (gram-negative)
Haemophilus influenzae
Bac (gram-negative)
Haemophilus influenzae type B
Bac (gram-negative)
Klebsiella pneumoniae
Bac (gram-negative)
Legionella pneumophila
Bac (gram-negative)
Moraxella catarrhalis
Bac (gram-negative)
Mycoplasma pneumoniae
Bac (gram-negative)
Salmonella spp. (typhi/paratyphi)
Bac (gram-negative)
Staphylococcus aureus
Bac (gram-positive)
Streptococcus agalactiae (Group-B)
Bac (gram-positive)
Streptococcus pneumoniae
Bac (gram-positive)
Streptococcus pyogenes (Group-A)
Bac (gram-positive)
Virus
21 targets
Enterovirus A71 (EV-A71)
ssRNA Virus
Enterovirus D68 (EV-D68)
ssRNA Virus
Human adenovirus types B, C, and E
ssRNA Virus
Human bocavirus types 1 and 3
ssRNA Virus
Human coronavirus 229E
ssRNA Virus
Human coronavirus HKU1
ssRNA Virus
Human coronavirus NL63
ssRNA Virus
Human coronavirus OC43
ssRNA Virus
Human gammaherpesvirus 4 (Epstein-Barr, Mono)
ssRNA Virus
Human metapneumovirus subgroups A and B
ssRNA Virus
Human parainfluenza virus 1
ssRNA Virus
Human parainfluenza virus 2
ssRNA Virus
Human parainfluenza virus 3
ssRNA Virus
Human parainfluenza virus 3Human parainfluenza virus 4
ssRNA Virus
Human parechovirus types 1, 3, 4, and 6
ssRNA Virus
Human rhinovirus A, B, and C
ssRNA Virus
Influenza A virus
ssRNA Virus
Influenza A virus (H1N1) swl
ssRNA Virus
Influenza B virus
ssRNA Virus
Respiratory syncytial virus (RSV) subgroups A and B
ssRNA Virus
SARS-CoV-2
ssRNA Virus
AMR
2 targets
Methicillin resistance (mecA)
AMR
Vancomycin resistance (vanA/vanB)
AMR

Comprehensive Pathogen Coverage

Bacterial Pathogens

Includes key causes of community-acquired and hospital-acquired respiratory infections:

Full bacterial panel detailed on page 1

Viral Pathogens

Covers a broad spectrum of seasonal, endemic, and emerging viruses

Viral targets detailed on page 1

Integrated Antimicrobial Resistance (AMR) Detection

AMR targets confirmed on page 1

Clinical Utility: Why This Panel Matters

1. Differentiates Viral vs. Bacterial Infections

2. Detects Co-Infections

3. Rapid Turnaround Time (~24 Hours)

4. Improves Infection Control & Public Health Response

5. Enables Targeted Therapy with AMR Insight

6. Enhances Care in High-Risk Populations

Clinical Scenarios Where This Panel Excels

Acute respiratory illness with unclear etiology

Severe or hospitalized pneumonia cases

Outbreak or seasonal respiratory surges

Persistent symptoms despite treatment

High-risk patient populations

Key Advantages at a Glance

Broad pathogen detection (viral + bacterial)

Co-infection identification

Integrated AMR profiling

Rapid turnaround (~24 hours)

High sensitivity vs. traditional testing

Supports antimicrobial stewardship

Elevating Respiratory Care Through Precision Diagnostics

This Respiratory PCR Panel empowers providers to:

Make faster, more accurate diagnoses

Deliver targeted, evidence-based treatment

Reduce antibiotic overuse

Improve patient outcomes and operational efficiency